MYGN Financial Facts

Total costs and expenses: 150.8M
Income tax provision (benefit): 1.5M
See Full Income Statement

Total stockholders' equity: -1.48B
Accrued liabilities: -91M
See Full Balance Sheet

Myriad Genetics Inc. (MYGN) Earnings

  |   Expand Research on MYGN
Next EPS Date 11/3/16 *Est. EPS Growth Rate -22.0% *Last Qtr.
Average EPS % Beat Rate +4.8% Revenue Growth Rate -1.8% *Last Qtr.
Average % Move 1-Wk after EPS -8.6% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/4/14 Q115 $0.25$0.32 -$0.07$168.8M$175M = Details
8/9/16 Q416 $0.32$0.38 -$0.06$186.5M$187.92M = Details
8/11/15 Q415 $0.41$0.42 -$0.01$189.9M$187.77M = Details
1/27/11 Q211 $0.26$0.26 $0.00$100.4M$98.84M Details
8/14/12 Q212 $0.34$0.34 $0.00$133M$131.85M = Details
5/5/15 Q315 $0.40$0.39 +$0.01$180M$183.3M = Details
11/2/10 Q111 $0.24$0.23 +$0.01N/AN/A Details
8/9/11 Q411 $0.30$0.29 +$0.01$107.4M$104.43M = Details